PacBio to Present at 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

PacBio (NASDAQ: PACB) announced its participation in the 41st Annual J.P. Morgan Healthcare Conference. The company will host a panel discussion on January 10, 2023, at 5:15 PM PT, focused on Multiomics. Additionally, a company presentation and Q&A session will take place on January 11, 2023, at 1:30 PM PT. Live webcasts will be available on PacBio's investors page, with replays accessible for 30 days post-event. PacBio specializes in advanced sequencing solutions aimed at resolving complex genetic problems.

MENLO PARK, Calif., Dec. 28, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following events at the 41st Annual J.P. Morgan Healthcare Conference:

• Panel | Multiomics: Markers for Modern Medicine on Tuesday, January 10, 2023, at approximately 5:15 PM PT.
• Company presentation and Q&A session on Wednesday, January 11, 2023, at approximately 1:30 PM PT.

The live webcasts of the events can be accessed at the company's investors page at investor.pacificbiosciences.com. Webcast replays will be available for at least 30 days following the presentation.

About PacBio

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB™ short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacb.com 

Media:
Lizelda Lopez
pr@pacb.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-present-at-41st-annual-jp-morgan-healthcare-conference-301710738.html

SOURCE Pacific Biosciences of California, Inc.

FAQ

What events is PacBio participating in at the J.P. Morgan Healthcare Conference 2023?

PacBio will participate in a panel on Multiomics on January 10, 2023, and a company presentation on January 11, 2023.

When will the PacBio panel discussion occur at the J.P. Morgan Healthcare Conference?

The PacBio panel discussion will take place on January 10, 2023, at approximately 5:15 PM PT.

What time is PacBio's company presentation at the J.P. Morgan Healthcare Conference?

PacBio's company presentation is scheduled for January 11, 2023, at approximately 1:30 PM PT.

Where can I access the webcasts of PacBio's presentations?

The live webcasts will be available on PacBio's investors page at investor.pacificbiosciences.com.

How long will the webcast replays for PacBio's conference events be available?

Webcast replays will be accessible for at least 30 days following the presentations.